Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA -Mutated and/or BRCAness Phenotype: A Randomized Phase III Trial

Lorusso, D.;Raspagliesi, F.;Ronzulli, D.;Valabrega, G.;Colombo, N.;Pisano, C.;Cassani, C.;Tognon, G.;Tamberi, S.;Mangili, G.;Mammoliti, S.;De Giorgi, U.;Greco, F.;Mosconi, A. M.;Breda, E.;Artioli, G.;Andreetta, C.;Casanova, C.;Ceccherini, R.;Frassoldati, A.;Salutari, V.;Giolitto, S.;Scambia, G.

2024-01-01